The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lydon Nicholas since year 2005.
The trader's CIK number is 1639935.
At the time of this reporting, Lydon Nicholas is the Director of Anaptysbio Inc .
(stock ticker symbol ANAB).
See this page for all insider trading activities at Anaptysbio Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-02-28||BPMC||Blueprint Medicines Corp||Sale||25,000||87.62||2,190,625|
|2018-02-15||ANAB||Anaptysbio Inc||Option Ex||16,483||4.55||74,997|
|2017-03-14||BPMC||Blueprint Medicines Corp||Sale||70,000||39.89||2,792,300|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lydon Nicholas (Director of Anaptysbio Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.